Target intelligence / Profile preview

RNA, U6 small nuclear 1121, pseudogene (RNU6-1121P)

Target
RNU6-1121P
Molecular classification
Other (Pseudogene; does not fall into classical categories like receptor, enzyme, etc.)
01

Overview

RNU6-1121P is a non-functional gene (pseudogene) representing a duplicated and inactive version of the gene coding for U6 small nuclear RNA. U6 snRNA plays a key role in pre-mRNA splicing as part of the spliceosome, but RNU6-1121P is not expressed to form functional snRNA and does not contribute to cellular processes. Pseudogenes like RNU6-1121P are common in vertebrate genomes where they serve as genetic remnants of evolution and do not encode active molecules or proteins[2][5][3]. Key distinctions: - U6 snRNA is critical for splicing[1][3], but RNU6-1121P is only a non-coding pseudogene copy without cellular function. - It is not a receptor, enzyme, transporter, channel, transcription factor, or any therapeutic target. - No drugs, no biomarkers, no direct relevance to human disease, and no therapeutic applications. If you are seeking information about the functional U6 snRNA, consult sources explicitly referring to the active gene, not its pseudogenes[1][3].

Other names
RNU6-1121PRNA, U6 small nuclear 1121, pseudogeneNCBI Gene: 106481780Ensembl: ENSG00000252611
02

Mechanism of action

None (not a drug target)

03

Biological functions

None (RNU6-1121P is a pseudogene, generally non-functional; authentic U6 snRNA is involved in RNA splicing, but pseudogenes do not participate in known cellular processes)
04

Disease associations

None (no direct role; pseudogenes may rarely be dysregulated, but RNU6-1121P has no established disease associations)
05

Safety considerations

None (not a therapeutic target)
06

Interacting drugs

None (no drugs interact with RNU6-1121P; it is not a target for pharmaceuticals)
07

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1121, pseudogene (RNU6-1121P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1121, pseudogene (RNU6-1121P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call